1. Home
  2. LFUS vs RGEN Comparison

LFUS vs RGEN Comparison

Compare LFUS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Littelfuse Inc.

LFUS

Littelfuse Inc.

HOLD

Current Price

$405.95

Market Cap

6.9B

Sector

Energy

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$116.90

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LFUS
RGEN
Founded
1927
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
6.6B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
LFUS
RGEN
Price
$405.95
$116.90
Analyst Decision
Strong Buy
Buy
Analyst Count
3
12
Target Price
$366.67
$167.67
AVG Volume (30 Days)
198.4K
817.5K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
0.75%
N/A
EPS Growth
N/A
286.96
EPS
N/A
0.86
Revenue
$757,853,000.00
$141,236,000.00
Revenue This Year
$14.65
$14.30
Revenue Next Year
$6.98
$14.52
P/E Ratio
N/A
$131.21
Revenue Growth
N/A
35.10
52 Week Low
$174.63
$109.50
52 Week High
$404.80
$175.77

Technical Indicators

Market Signals
Indicator
LFUS
RGEN
Relative Strength Index (RSI) 72.82 42.86
Support Level $249.00 $111.29
Resistance Level N/A $131.93
Average True Range (ATR) 9.69 6.15
MACD 2.51 -0.27
Stochastic Oscillator 94.79 23.16

Price Performance

Historical Comparison
LFUS
RGEN

About LFUS Littelfuse Inc.

Littelfuse is a primary provider of circuit protection products (such as fuses and relays) for the transportation, industrial, telecommunications, and consumer electronics end markets. The company is also increasing its power semiconductor business, where it predominantly serves industrial end markets, and is breaking into electric vehicle charging infrastructure. Littelfuse has 17,000 global employees.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: